Recruiting

Multi-Ingredient Creatine

Sponsor:

University of Northern Iowa

Code:

NCT07940010

Conditions

Exercise Performance

Cognitive Performance

Eligibility Criteria

Sex: All

Age: 18 - 40

Healthy Volunteers: Accepted

Interventions

Creatine Monohydrate

Multi-Ingredient Creatine Formulation

Study Details

Brief summary:

This study will examine whether a multi-ingredient creatine supplement produces different effects on exercise performance, cognitive function, hydration, and gastrointestinal symptoms compared with creatine monohydrate alone.

Approximately 16 healthy, physically active adults aged 18-40 years will participate. Each participant will take creatine monohydrate (5 grams per day) for 18 days and a multi-ingredient supplement containing creatine monohydrate (5 grams), sodium, potassium, magnesium, and taurine for another 18 days. The order of supplementation will be randomly assigned, with a 30-day break between conditions.

Participants will complete laboratory testing before and after each supplementation period. Testing will include bench press exercise to assess muscular endurance, repeated high-intensity cycling tests to assess exercise performance, and a computerized cognitive task to measure attention and reaction time. Researchers will also assess hydration, selected blood markers, perceived exertion, and gastrointestinal symptoms.

The findings may help determine whether adding electrolytes and taurine to creatine provides additional benefits or produces different physiological responses compared with creatine monohydrate alone.

Conditions

Exercise Performance

Cognitive Performance

Study ID

NCT07940010

Start date

Nov 13, 2026

Status verified date

Nov, 2026

Completion date

May 31, 2027

Anticipated

Primary completion date

May 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 40

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Adults aged 18-40 years.
  • Apparently healthy individuals who are physically active and capable of performing vigorous exercise.
  • Willing and able to complete repeated maximal-intensity cycling tests, bench press exercise, and cognitive assessments.
  • Willing to consume both assigned dietary supplement formulations for 18 days each, separated by a 30-day washout period.
  • Willing to refrain from taking additional creatine or electrolyte supplements during the study, including the washout period.
  • Able and willing to provide written informed consent.

Exclusion Criteria:

  • History of cardiovascular, metabolic, renal, neurological, or musculoskeletal conditions that may contraindicate vigorous exercise or interfere with study outcomes.
  • Current injury or physical limitation that would prevent safe completion of the exercise testing procedures.
  • Current pregnancy or plans to become pregnant during the study.
  • Recent creatine supplementation prior to enrollment.
  • Current use of medications or dietary supplements that may interfere with creatine metabolism, hydration status, exercise performance, cognitive function, or participant safety.
  • Known allergy, intolerance, or contraindication to any ingredient in the study supplements.
  • Unwillingness or inability to comply with supplementation, washout, or laboratory testing requirements.

Study Design

Enrollment

16 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Creatine Monohydrate Followed by Multi-Ingredient Creatine

Participants will receive creatine monohydrate (5 g/day) with sugar-free flavoring for 18 consecutive days, followed by a 30-day washout period. Participants will then receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period.

experimental: Multi-Ingredient Creatine Followed by Creatine Monohydrate

Participants will receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for 18 consecutive days, followed by a 30-day washout period. Participants will then receive creatine monohydrate (5 g/day) with sugar-free flavoring for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period.

Interventions

Creatine Monohydrate

Participants will consume 5 g/day of creatine monohydrate mixed with sugar-free flavoring for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Multi-Ingredient Creatine Formulation

Participants will consume a multi-ingredient dietary supplement containing creatine monohydrate (5 g), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) daily for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Primary outcome measure

  • Total Bench Press Repetitions [ Time Frame: Baseline and Day 18 of each supplementation period. ]
  • Peak Power During Repeated Wingate Tests [ Time Frame: Baseline and Day 18 of each supplementation period. ]
  • Mean Power During Repeated Wingate Tests [ Time Frame: Baseline and Day 18 of each supplementation period. ]
  • Total Work During Repeated Wingate Tests [ Time Frame: Baseline and Day 18 of each supplementation period. ]
  • Stroop Interference Reaction Time [ Time Frame: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day). ]
  • Stroop Task Accuracy [ Time Frame: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day). ]

Central Contacts and Locations

Central contacts

Locations

Wellness and Recreation Center

Recruiting

Cedar Falls, Iowa, United States, 50614

Contacts

More Information

Sponsor

University of Northern Iowa

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by University of Northern Iowa on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.